University College Dublin
His primary scientific interests are in Internal medicine, Weight loss, Endocrinology, Obesity and Surgery. His research on Internal medicine often connects related areas such as Gastroenterology. His Weight loss study combines topics from a wide range of disciplines, such as Taste, Randomized controlled trial, Systemic inflammation and Bile acid.
Endocrinology is closely attributed to Peptide YY in his research. The study incorporates disciplines such as Microbiome, Bioinformatics, Energy expenditure and Disease in addition to Obesity. His biological study spans a wide range of topics, including Gastrectomy, MEDLINE, Malabsorption, Blood pressure and Type 2 diabetes.
Carel W. le Roux mostly deals with Internal medicine, Weight loss, Surgery, Obesity and Endocrinology. His Internal medicine study integrates concerns from other disciplines, such as Diabetes mellitus, Type 2 diabetes and Gastroenterology. His Weight loss research incorporates elements of Body mass index, Malabsorption, Meal and Intensive care medicine.
The Surgery study combines topics in areas such as Metabolic surgery, Sleeve gastrectomy, Glycemic and Insulin resistance. His Obesity study incorporates themes from Liraglutide, Disease, Type 2 Diabetes Mellitus and Prediabetes. As a part of the same scientific study, Carel W. le Roux usually deals with the Endocrinology, concentrating on Peptide YY and frequently concerns with Ghrelin.
His primary areas of study are Obesity, Type 2 diabetes, Surgery, Internal medicine and Weight loss. In Obesity, Carel W. le Roux works on issues like Prospective cohort study, which are connected to Canagliflozin. His studies deal with areas such as Placebo, Albuminuria, Kidney disease and Glycemic as well as Type 2 diabetes.
His study in Surgery is interdisciplinary in nature, drawing from both Body mass index, Sleeve gastrectomy and Insulin resistance. His studies in Internal medicine integrate themes in fields like Gastroenterology, Endocrinology and Prediabetes. His Weight loss research is multidisciplinary, relying on both Liraglutide, Hormone, Ghrelin, Carbohydrate metabolism and Appetite.
Carel W. le Roux focuses on Obesity, Internal medicine, Surgery, Weight loss and Type 2 diabetes. Carel W. le Roux combines subjects such as Observational study and Environmental health with his study of Obesity. His Internal medicine research focuses on subjects like Endocrinology, which are linked to Peptide YY.
His study looks at the relationship between Surgery and topics such as Sleeve gastrectomy, which overlap with Meal. His work in Weight loss covers topics such as Ghrelin which are related to areas like Gastroenterology, Glucose homeostasis and Roux-en-Y anastomosis. The concepts of his Type 2 diabetes study are interwoven with issues in Placebo and Albuminuria, Kidney disease.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Inhibition of food intake in obese subjects by peptide YY3-36.
Rachel L Batterham;Mark A Cohen;Sandra M Ellis;Carel W Le Roux.
The New England Journal of Medicine (2003)
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
Xavier Pi-Sunyer;Arne Astrup;Ken Fujioka;Frank Greenway.
The New England Journal of Medicine (2015)
Gut Hormone Profiles Following Bariatric Surgery Favor an Anorectic State, Facilitate Weight Loss, and Improve Metabolic Parameters
Carel W. le Roux;Simon J. B. Aylwin;Rachel L. Batterham;Cynthia M. Borg.
Annals of Surgery (2006)
Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass.
Carel W. le Roux;Richard Welbourn;Malin Werling;Alan Osborne.
Annals of Surgery (2007)
Critical role for peptide YY in protein-mediated satiation and body-weight regulation
Rachel L. Batterham;Helen Heffron;Saloni Kapoor;Joanna E. Chivers.
Cell Metabolism (2006)
Roux-en-Y Gastric Bypass and Vertical Banded Gastroplasty Induce Long-Term Changes on the Human Gut Microbiome Contributing to Fat Mass Regulation
Valentina Tremaroli;Fredrik H. Karlsson;Malin Werling;Marcus Ståhlman.
Cell Metabolism (2015)
Oxyntomodulin Suppresses Appetite and Reduces Food Intake in Humans
Mark A. Cohen;Sandra M. Ellis;Carel W. Le Roux;Rachel L. Batterham.
The Journal of Clinical Endocrinology and Metabolism (2003)
Morbidity and mortality associated with obesity.
Mahmoud Abdelaal;Mahmoud Abdelaal;Carel W. le Roux;Carel W. le Roux;Carel W. le Roux;Neil G. Docherty;Neil G. Docherty.
Annals of Translational Medicine (2017)
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
Carel W le Roux;Carel W le Roux;Arne Astrup;Ken Fujioka;Frank Greenway.
The Lancet (2017)
The Role of Bile After Roux-en-Y Gastric Bypass in Promoting Weight Loss and Improving Glycaemic Control
Dimitri J. Pournaras;Clare Glicksman;Royce P. Vincent;Royce P. Vincent;Shophia Kuganolipava.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: